Search Tag: Chemotherapy

Executive Health Management

2023 14 Aug

Patients undergoing treatment for ovarian cancer often encounter peripheral neuropathy, an adverse effect of chemotherapy that can lead to persistent pain and numbness lasting for months or even years.   A recent Yale study suggests that engaging in aerobic exercise for a period of up to six months can offer relief from this side effect.  ...Read more

Executive Health Management

2022 18 Oct

Hybrid Event PROSCA: 18 & 19 October 2022 BLADDR: 20 & 21 October 2022 Find Mirrors of Medicine on Social Media Read more

Executive Health Management

2019 26 Aug

Summary: Cancer affects everybody's life at some point. ‘The Death of Cancer,' written by one of oncology's leading figures, Dr Vincent T. DeVita, documents his own journey for the cure. Dr Peter Kapitein gives his personal review on the book.   In 2005 I was diagnosed with lymph gland cancer and became interested in the medical industrial...Read more

Executive Health Management

2018 07 Nov

Hyperthermia can further enhance the therapeutic outcomes of radiation and chemotherapy, while keeping side effects at a minimum. A treatment method with many advantages. What is hyperthermia? Hyperthermia is the intentional overheating for therapeutic purposes, either throughout the body or in individual organs. The method of directly...Read more

Executive Health Management

2016 25 Jan

If you compare how people near the end of life are treated in the U.S. and other regions of the world, you will find very specific differences. In the U.S, such patients are typically attached to tubes and machines. They also have to go through invasive procedures and because of the fact that they are inundated with all these measures, most of the...Read more

Executive Health Management

2015 06 Oct

Results from the largest international comparison of the treatment of elderly patients with breast cancer show that significant differences exist in the use of surgery, hormone therapy and chemotherapy between European countries. The European Registration of Cancer Care (EURECCA) study compared the treatment of elderly patients (70 years...Read more

Executive Health Management

2015 01 Apr

Breast, colorectal and lung cancers may respond to a less-toxic class of drugs as well as they do to chemotherapy when the drugs are used in combination with fasting. The results of two new studies in mice, conducted by a multinational collaboration of researchers, have been published in the March 30 issue of Oncotarget . Starving Cancer Cells...Read more